ℹ️ Compiled from public regulatory records · Last regulator revision: April 17, 2026🚩 Report this page
Xipamide
Sulfonamides, Plain
GB MHRA
- Drug class
- Sulfonamides, Plain
- Availability
- See label
- Markets covered
- 1
- Products on record
- 1
Overview
Xipamide is an active pharmaceutical ingredient in the Sulfonamides, Plain group (C03BA). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 1 | April 17, 2026 |
GBUnited Kingdom· MHRA
1 product
1 product on record with this regulator. Detailed label text (uses, dosage, side effects) is being ingested — the original document is linked under Sources [1].
Sources & citations
- [1]MHRA (UK) · PL463020127 · revised April 17, 2026
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.